ResMed, A US based digital health and cloud-connected medical devices company, has expanded AirView for Ventilation, its cloud-based remote monitoring and management platform for respiratory care patients, in India.

ResMed’s AirView platform allows healthcare professionals to monitor large numbers of patients remotely, safely, and efficiently, enabling them to quickly support those who need it, optimising their device use and health outcomes.

AirView connects with ResMed’s respiratory care devices such as Lumis through a built-in wireless module, and with Astral and Stellar ventilators through a ResMed Connectivity Module (RCM).

AirView enables:

• a comprehensive view of patients’ therapy data that enables authorised members of the care team to interpret and optimise patient therapy outcomes,
• filtering patients into actionable groups based on a specific therapy issue they may be having that need immediate attention,
• easier identification of patients that require assistance,
• reduced lengthy or unnecessary or unscheduled visits,
• remote troubleshooting to resolve patient therapy and device issues - greater flexibility in managing patients in compliance with regulatory guidelines.

Carlos Montiel, Vice President, Latin America and South Asia, Asia and Latin, ResMed, said. “AirView allows healthcare providers to remotely monitor and assess patients and ultimately tailor treatments. It helps save time by identifying therapy issues early in the process and enabling relevant solutions, thereby optimising therapy use.”

Currently, more than 15 million patients with cloud-connectable devices in ResMed’s global network are allowing doctors to remotely monitor their patients for the diagnosis and treatment of their sleep and respiratory disorders.

AirView for Ventilation is already available in the US and across Europe.